93 related articles for article (PubMed ID: 16321859)
1. N-RAS and K-RAS gene mutations in Brazilian patients with multiple myeloma.
Ortega MM; Faria RM; Shitara ES; Assis AM; Albuquerque DM; Oliveira JS; Noguti MA; Faria JR; Costa FF; Lima CS
Leuk Lymphoma; 2006 Feb; 47(2):285-9. PubMed ID: 16321859
[TBL] [Abstract][Full Text] [Related]
2. p53 and RAS gene mutations in multiple myeloma.
Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
[TBL] [Abstract][Full Text] [Related]
3. RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
Matozaki S; Nakagawa T; Nakao Y; Fujita T
Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261
[TBL] [Abstract][Full Text] [Related]
4. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer.
Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN
Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179
[TBL] [Abstract][Full Text] [Related]
5. Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China.
Chen HC; Chen HJ; Khan MA; Rao ZZ; Wan XX; Tan B; Zhang DZ
Tumour Biol; 2011 Apr; 32(2):367-73. PubMed ID: 21080251
[TBL] [Abstract][Full Text] [Related]
6. N-ras and p53 gene mutations are very rare events in multiple myeloma.
Yasuga Y; Hirosawa S; Yamamoto K; Tomiyama J; Nagata K; Aokia N
Int J Hematol; 1995 Aug; 62(2):91-7. PubMed ID: 8590778
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between N-ras gene mutations and clinical prognosis in Brazilian children with acute lymphoblastic leukemia.
Clementino NC; Yamamoto M; Viana MB; Figueiredo MS; Kerbauy J; Saad ST; Costa FF
Leuk Lymphoma; 2001 Jul; 42(3):473-9. PubMed ID: 11699412
[TBL] [Abstract][Full Text] [Related]
8. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
9. A high frequency of N-RAS oncogene mutations in multiple myeloma.
Tanaka K; Takechi M; Asaoku H; Dohy H; Kamada N
Int J Hematol; 1992 Oct; 56(2):119-27. PubMed ID: 1421173
[TBL] [Abstract][Full Text] [Related]
10. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
[TBL] [Abstract][Full Text] [Related]
11. Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation.
Kalakonda N; Rothwell DG; Scarffe JH; Norton JD
Blood; 2001 Sep; 98(5):1555-60. PubMed ID: 11520807
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes in multiple myeloma: point mutation of N-ras.
Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
14. The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or K-ras alleles in human bone marrow aspirates.
Millar BC; Bell JB; Barfoot R; Everard M
Br J Cancer; 1995 Feb; 71(2):259-64. PubMed ID: 7841038
[TBL] [Abstract][Full Text] [Related]
15. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
Martín P; Santón A; García-Cosío M; Bellas C
Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
18. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
19. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras mutations in resected primary leiomyosarcoma.
Hill MA; Gong C; Casey TJ; Menon AG; Mera R; Gillespie AT; Giardina JF; Levine EA; Hunt JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1095-100. PubMed ID: 9419409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
